Press Releases

Mar 29, 2019
Bicycle Therapeutics to Present Preclinical Data on EphA2 and Nectin-4 Bicycle Toxin Conjugate Programs, as well as a CD137 Immune Oncology Program, at the American Association for Cancer Research Annual Meeting
CAMBRIDGE, U.K., and BOSTON, Mass., March 29, 2019  –  Bicycle Therapeutics , a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) product platform, announced today that Bicycle scientists have been selected to present two oral
Feb 20, 2019
Bicycle Therapeutics Strengthens Executive Team with Key Changes
Peter Leone Appointed Chief Business Officer Lee Kalowski, Chief Financial Officer, Promoted to U.S. President CAMBRIDGE, U.K., and BOSTON, Mass., February 20, 2019 –  Bicycle Therapeutics , a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (
Displaying 21 - 26 of 26